Pharmacological Therapies for Obesity and Metabolic Disorders

Pharmacotherapy represents a critical component of obesity treatment when lifestyle modification alone is insufficient. Current drug therapies target appetite regulation, energy expenditure, and nutrient absorption, with agents including GLP-1 receptor agonists, GIP analogues, and lipase inhibitors. Novel therapies are being developed to address multiple metabolic pathways simultaneously, offering broader efficacy. Safety, long-term outcomes, and adherence remain challenges, but ongoing research into dual and triple hormone agonists and gene-targeted drugs holds promise for revolutionizing medical management of obesity and its metabolic complications.

    Related Conference of Pharmacological Therapies for Obesity and Metabolic Disorders

    October 20-21, 2025

    25th Global Summit on Obesity

    Dubai, UAE
    March 26-27, 2026

    28th Global Obesity Meeting

    London, UK
    June 15-16, 2026

    22nd Euro Obesity and Endocrinology Congress

    Amsterdam, Netherlands

    Pharmacological Therapies for Obesity and Metabolic Disorders Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in